Preview: Pactiv Evergreen’s Earnings

Pactiv Evergreen (NASDAQ:PTVE) is set to give its latest quarterly earnings report on Monday, 2022-11-07. Here's what investors need to know before the announcement. Analysts estimate that Pactiv Evergreen will report an earnings per share (EPS) of $0.14.

Pactiv Evergreen (NASDAQ:PTVE) is set to give its latest quarterly earnings report on Monday, 2022-11-07. Here’s what investors need to know before the announcement.

Analysts estimate that Pactiv Evergreen will report an earnings per share (EPS) of $0.14.

Pactiv Evergreen bulls will hope to hear the company to announce they’ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Historical Earnings Performance

Last quarter the company beat EPS by $0.20, which was followed by a 14.47% increase in the share price the next day.

Here’s a look at Pactiv Evergreen’s past performance and the resulting price change:

 

Quarter Q2 2022 Q1 2022 Q4 2021 Q3 2021
EPS Estimate 0.2 0.11 0.43 0.09
EPS Actual 0.4 0.24 0.19 0.01
Price Change % 14.47% 4.28% -2.95% -1.53%

eps graph

Stock Performance

Shares of Pactiv Evergreen were trading at $10.6 as of November 03. Over the last 52-week period, shares are down 24.63%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release.

To track all earnings releases for Pactiv Evergreen visit their earnings calendar on our site.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

Pervasip Reports Slight YoY Decrease In Q1 Revenue As It Prepares For Cannabis Spin-Off

Pervasip announced on Tuesday its 2024 first-quarter financial results. Simultaneously, the Seattle, Washington-based company said it's still in the restructuring process and preparation for the spin-out of all of its cannabis assets. "We are entering our final phase of restructuring which involves making difficult decisions to ensure additional expense reductions and separating the company from assets it has held for many years," German Burtscher, Pervasip's president and chief executive officer, said. Additionally, as part of the restructuring, George Jordan has resigned from his duties as CFO and COO of the company and will stay on as an advisor, supporting management through its final phase of changes in preparation for the spin-out of Artizen Corporation.

PVSP